Well spotted - where is the official announcement on recruitment/commencement from Biota?
So this is a trial on Healthy Adults. Is this a precursor to go at broad spectrum HRV treatment?
Primary Outcome Measures:
Systemic exposure profile of a single dose of a vapendavir 300 mg tablet compared to the exposure profile following a single dose of two 132 mg vapendavir capsules [ Time Frame: maximum up to 46 days ] [ Designated as safety issue: No ]
PK and statatistical analyses will be performed to determine the Primary Outcome Measure
Estimated Enrollment: 36
Study Start Date: March 2014
Estimated Primary Completion Date: June 2014 (Final data collection date for primary outcome measure)
----------
Refreshing to know that a Biota trial can be started and completed over a period of 4 months and with less than 36 enrolled! Obviously Phase 1 trials are typically small enrollments. Any thoughts on Phase 2 possible enrollment size and again, the ultimate goal?
----------
Speaking of HRV Trials, just found this - happening right under our nasal passages in Victoria :-)
http://www.youtube.com/watch?v=QAGm8ejFDtU
Back to seriousness, here is a company forging forward in the RSV space:
http://www.aliosbiopharma.com/news_room/press_releases/alios_biopharma_reports_significant_progress_with_its_clinical_program_for
Add to My Watchlist
What is My Watchlist?